Unknown PHASE4 INTERVENTIONAL 3-arm NCT03090698

Outcomes of Injections in Patients Waiting for Total Knee Replacement

Viscosupplementation in Patients With Severe Osteoarthritis of the Knee

Sponsor: Universidade Federal Fluminense

Interventions Hylan G-F 20 Triamcinolone

Updated 6 times since 2017 Last updated: Mar 20, 2017 Started: Sep 30, 2015 Primary completion: Apr 30, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03090698, this PHASE4 trial focuses on Osteoarthritis of the Knee and remains ongoing. Sponsored by Universidade Federal Fluminense, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

May 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Federal Fluminense

Data source: Universidade Federal Fluminense

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rio de Janeiro, Brazil